Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

• Status: Completed
• Trial end date: 2014-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to provide a holistic assessment of patients receiving etanercept in a real-world setting.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Etanercept

Criteria

Inclusion Criteria:

• Diagnosis of ankylosing spondylitis (AS)

Exclusion Criteria:

• Hypersensitivity to etanercept

• Active infection including chronic or localised infection

• Sepsis or risk of sepsis